Arterys Cardio DL vs PMcardio

PMcardio offers a mobile app (iOS and Android) and a web platform, allowing for flexible access and immediate use without IT integration. Users can simply download the app and start scanning ECGs. Arterys Cardio DL is cloud-based but focuses on cardiac MRI analysis, which typically involves more complex workflows and dedicated imaging workstations, suggesting a less immediate 'out-of-the-box' usability for a broad range of clinicians compared to PMcardio's mobile-first approach for ECGs.

PMcardio is clinically validated in over 25 studies and detects more than 50 cardiac conditions from ECGs, including critical conditions like STEMI/OMI and reduced LVEF, with reported improvements in sensitivity and reduction in false positives. It also provides AI explainability with heatmaps and patient management recommendations. Arterys Cardio DL focuses on automated ventricle segmentations for cardiac MRI, significantly reducing interpretation time and enhancing diagnostic accuracy for MRI analysis. While both offer significant clinical value in their respective domains, PMcardio's broader detection capabilities across numerous conditions from a more accessible diagnostic tool (ECG) and its proven impact on reducing false activations and improving treatment times give it an edge in overall clinical utility for a wider range of healthcare professionals.

PMcardio offers a freemium model with a free plan for 5 ECG analyses per month, and transparent pricing for individual and team subscriptions. This allows users to experience the tool before committing financially. Arterys Cardio DL's pricing is available upon contact, suggesting a less transparent and potentially higher-cost enterprise-focused model.

PMcardio is designed for enterprise deployment, offering integrations with existing ECG systems, EHR/CVIS, and EMS systems, with features like governance, role-based access, and workflow alignment. It also boasts SOC 2 Type II, ISO 27001, GDPR, and HIPAA compliance. Arterys Cardio DL is cloud-based and HIPAA compliant with BAA, but the available information doesn't detail the same breadth of enterprise-specific integrations and features as PMcardio.

Both tools demonstrate innovation in their respective fields. Arterys Cardio DL was the first FDA-cleared cloud-based AI for medical imaging with deep learning capabilities for cardiac MRI. PMcardio, however, offers several innovative features, including detection of over 50 cardiac conditions from ECGs, visual AI explainability (ECGxplainu2122) with heatmaps, and AI confidence scores for culprit artery detection. Its ability to digitize and interpret even old or damaged ECG strips also highlights a practical innovation.

PMcardio provides a Help Center with user-friendly tutorials and manuals, FAQs, and legal documents readily available online. It also offers email support for individuals and dedicated customer success managers for enterprise clients. Information regarding Arterys Cardio DL's specific support and documentation offerings is not as explicitly detailed in the provided facts, making PMcardio appear more robust in this dimension.